OncoMatch/Clinical Trials/NCT07652580
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Is NCT07652580 recruiting? Yes, currently enrolling (Sep 2026).
RecruitingHenry M. Jackson Foundation for the Advancement of Military MedicineNCT07652580Data as of Sep 2026
Check if I qualifyExtracted eligibility criteria
Cancer type
Non-Hodgkin Lymphoma
Demographics
Ages ≥ 4
Prior therapy
Cannot have received: induction treatment for NHL
Actively undergoing induction treatment for NHL
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Uniformed Services University of the Health Sciences · Bethesda, Maryland
- Walter Reed National Military Medical Center · Bethesda, Maryland
- Naval Medical Center Portsmouth · Portsmouth, Virginia
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07652580 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior induction treatment for NHL disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages